1. Administration, U. F. Code of federal regulations, 2013. Title 21. Volume 4 Department of Health and Human Services; USA.
2. Design control considerations for biologic device combination products;Anderson;Adv. Drug Deliv. Rev.,2017
3. Factor VIII delivery devices in Haemophilia A. Barriers and drivers for treatment adherence;Arias;Farm. Hosp.,2016
4. Demonstrating the stability of albinterferon alfa-2b in the presence of silicone oil;Auge;J. Pharm. Sci.,2011
5. Utility and application of analytical and safety thresholds for the evaluation of extractables and leachables in drug products;Ball;Am. Pharm. Rev.,2007